Thackray Helen M. (CIK 1589725) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-04-02). Recent activity: Sell BCRX (7,525 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Chief R&D Officer | Sell | 7,525 | $56,438 |
Source: SEC Form 4 filings · as of 2025-04-02